Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results for PINK:RHHBY
30.77
-1.59 (-4.91%)
After Hours: 30.67 -0.10 (-0.32%)
Jun 24, 4:00PM EDT  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 30.53 - 31.59
52 week 29.89 - 36.94
Open 30.97
Vol / Avg. 986,870.00/1.24M
Mkt cap 215.52B
P/E 22.94
Div/yield 1.02/3.31
EPS 1.34
Shares 692.02M
Beta 0.73
Inst. own 16%
Sep 21, 2016
Roche Holding AG at Sanford C Bernstein Pan European Conference Add to calendar
Sep 16, 2016
Roche Holding AG at UBS Best of Switzerland Conference Add to calendar
Sep 15, 2016
Roche Holding AG at Bank of America Merrill Lynch Healthcare Conference Add to calendar
Sep 12, 2016
Roche Holding AG at Morgan Stanley Global Healthcare Conference Add to calendar
Sep 7, 2016
Roche Holding AG at Goldman Sachs Medtech Conference Add to calendar
Aug 23, 2016
Roche Holding AG at Bank am Bellevue Healthcare Day Add to calendar
Aug 10, 2016
Roche Holding AG at UBS Genomics 2.0 Summit Add to calendar
Aug 2, 2016
Roche Analyst Event on Diagnostics Division at AACC 2016 - Philadelphia - 6:00PM EDT - Add to calendar
Jul 21, 2016
Half Year 2016 Roche Holding AG Earnings Call - 7:00AM EDT - Add to calendar
Jul 21, 2016
Half Year 2016 Roche Holding AG Earnings Release - 1:00AM EDT - Add to calendar
  

Key stats and ratios

Q4 (Dec '15) 2015
Net profit margin 15.50% 18.81%
Operating margin 23.30% 27.89%
EBITD margin - 40.92%
Return on average assets 10.50% 11.97%
Return on average equity 38.85% 43.70%
Employees 91,747 -
CDP Score - 100 A

Address

Grenzacherstr. 124
BASEL, 4058
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG is a research-based healthcare company. The Company develops, manufactures and delivers medicines, and diagnostic instruments and tests. Its operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. Its Pharmaceuticals division consists of two business segments: Roche Pharmaceuticals and Chugai. Its Diagnostics division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. It develops medicines for the disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its product portfolio consists of Pharmaceuticals, Solutions for Diagnostics and Products for Researchers. Its Pharmaceutical products include ACTEMRA and CellCept. Its Solutions for Diagnostics products include Accu-Chek Active System and Accu-Chek Aviva Nano System. The Company's Products for Researchers include Cedex HiRes and Genome Sequencer FLX System.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Director
Age: 49
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 49
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 54
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Age: 52
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
Age: 68
John C. Reed M.D., Ph.D. Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 58
Michael David Varney Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 58
Urs Jaisli Chief Compliance Officer
Age: 60
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 62
Silvia Ayyoubi Member of the Corporate Executive Committee, Head Group Human Resources
Age: 63